UFA
RPRX icon

Unify Financial Advisors’s Royalty Pharma RPRX Stock Holding History

Unify Financial Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$494K Sell
8,802
-35
-0.4% -$1.82K 0.46% 56
2026
Q1 		$424K Sell
8,837
-1,385
-14% -$60.7K 0.44% 63
2025
Q4 		$395K Buy
+10,222
New +$390K 0.41% 66

Other funds holding RPRX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
KMC
Kirr Marbach & Co Columbus, Indiana $594M AUM 34% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
SMDAM
Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.5B AUM 37.68% 1-Year Est. Return

Unify Financial Advisors's RPRX Position: Q2 2026 in Review

Unify Financial Advisors reduced its Royalty Pharma (RPRX) stake by 0.4% in Q2 2026, selling an estimated $1.82K and leaving 8,802 shares worth $494K. The position accounts for 0.46% of the portfolio, ranked #56.

Unify Financial Advisors first reported a position in RPRX in Q4 2025 and has held it in 3 quarters since. 91 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Unify Financial Advisors held 8,802 shares of Royalty Pharma worth $494K as of Q2 2026.
  • Unify Financial Advisors sold 35 Royalty Pharma shares in Q2 2026, an estimated $1.82K.
  • Royalty Pharma made up 0.46% of Unify Financial Advisors's portfolio in Q2 2026, its #56 holding.
  • Unify Financial Advisors first reported a position in Royalty Pharma in Q4 2025 and has held it in 3 quarters since.
  • 91 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Unify Financial Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.